Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 6/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ACACB | O00763 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | STAT5B | P51692 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2372675 | 0.78 | L3MBTL1 (0.49) | SCDL3MBTL1KDM4EPOLBALOX15 | |
| SCHEMBL11080584 | 0.78 | SCD (0.46) | SCDL3MBTL1NPSR1KDM4EMAPT | |
| SCHEMBL16506482 | 0.76 | ALDH1A1 (0.43) | SCDL3MBTL1NPSR1KDM4EALDH1A1 | |
| SCHEMBL15360305 | 0.74 | NPSR1 (0.46) | SCDL3MBTL1NPSR1KDM4EMAPT | |
| SCHEMBL15529175 | 0.74 | MAPT (0.57) | NPSR1KDM4EMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL71518 | 0.73 | NPSR1 (0.59) | L3MBTL1NPSR1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL1465529 | 0.73 | KDR (0.46) | KDM4EMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL270613 | 0.72 | SCD (0.34) | SCDL3MBTL1 | |
| SCHEMBL7931401 | 0.70 | L3MBTL1 (0.40) | SCDL3MBTL1NPSR1KDM4ESMN1; SMN2 | |
| SCHEMBL11087406 | 0.70 | ALDH1A1 (0.40) | SCDL3MBTL1NPSR1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921273-B2 | Substituted pyridazines having herbicidal action | BASF SE (DE) | 2014-12-30 | — | — | US | disclosed |
| US-8921273-B2 | Substituted pyridazines having herbicidal action | BASF SE (DE) | 2014-12-30 | — | — | US | disclosed |
| US-20130012388-A1 | Pyrazinothiazines Having Herbicidal Action | BASF SE (DE) | 2013-01-10 | — | — | US | disclosed |
| US-20130012388-A1 | Pyrazinothiazines Having Herbicidal Action | BASF SE (DE) | 2013-01-10 | — | — | US | disclosed |
| US-20130005576-A1 | Substituted Pyridazines Having Herbicidal Action | BASF SE (DE) | 2013-01-03 | — | — | US | disclosed |
| US-20130005576-A1 | Substituted Pyridazines Having Herbicidal Action | BASF SE (DE) | 2013-01-03 | — | — | US | disclosed |
| WO-2011117151-A1 | PYRAZINOTHIAZINES HAVING HERBICIDAL ACTION | BASF SE (DE) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011117273-A1 | SUBSTITUTED PYRIDAZINES HAVING HERBICIDAL ACTION | BASF SE (DE) | 2011-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005576-A1 | Substituted Pyridazines Having Herbicidal Action | PNPO, PLPBP, CYP4Z1 | SCD 3776/4885L3MBTL1 4314/4885NPSR1 1525/4885 |
| US-20130012388-A1 | Pyrazinothiazines Having Herbicidal Action | PNPO, CYP4Z1, CAT | SCD 4451/4885L3MBTL1 4346/4885NPSR1 2483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.